Clinical trial
Combination Chemotherapy With or Without Interferon Alfa in Treating Patients…
NCT00003639 · Scotland and Newcastle Lymphoma Group, Other · Unknown status
Key facts
| NCT number | NCT00003639 |
|---|---|
| Title | Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma |
| Official title | Randomised Controlled Trial of CID (Chlorambucil, Idarubicin, Dexamethasone) Versus CD (Chlorambucil, Dexamethasone) for Induction of Remission in Low Grade Non-Hodgkin's Lymphoma (Kiel Classification) Followed by Randomised Controlled Assessment of Standard Dose Interferon Versus Low Dose… |
| Lead sponsor | Scotland and Newcastle Lymphoma Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, chlorambucil, dexamethasone, idarubicin |
| Enrollment | 200 |
| Start date | Nov 1, 1993 |
| First posted | Jul 16, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: